Literature DB >> 3142905

Complement split products and the pathogenesis of SLE.

S B Abramson1, G Weissmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3142905     DOI: 10.1080/21548331.1988.11703590

Source DB:  PubMed          Journal:  Hosp Pract (Off Ed)        ISSN: 8750-2836


× No keyword cloud information.
  3 in total

1.  Cerebral occlusive vasculopathy in systemic lupus erythematosus and speculation on the part played by complement.

Authors:  A Hammad; Y Tsukada; N Torre
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

Review 2.  Clinical utility of complement assessment.

Authors:  A E Ahmed; J B Peter
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

3.  Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET.

Authors:  S M Weiner; A Otte; M Schumacher; R Klein; J Gutfleisch; I Brink; P Otto; E U Nitzsche; E Moser; H H Peter
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.